β-carotene-induced changes in RARβ isoform mRNA expression patterns do not influence lung adenoma multiplicity in the NNK-initiated A/J mouse model

Nutrition and Cancer

Volumn 54, Issue 2, 2006, Pages 252-262

  Goralczyk, Regina ^a   Bachmann, Heinrich ^b   Wertz, Karin ^a   Lenz, Barbara ^b   Riss, Georges ^a   Hunziker, Petra Buchwald ^a   Greatrix, Brad ^a   Aebischer, Claude Pierre ^a  

^a DSM NUTRITIONAL PRODUCTS LTD   (Switzerland)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; BETA CAROTENE; MESSENGER RNA; RETINOIC ACID RECEPTOR BETA; RETINOL; RETINOL ESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET SUPPLEMENTATION; DIETARY INTAKE; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; GENE CONTROL; GENE EXPRESSION; LUNG ADENOMA; LUNG CARCINOGENESIS; MALE; MOUSE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; TUMOR MODEL;

ADENOMA; ANIMALS; BETA CAROTENE; CARCINOGENS; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MICE; NITROSAMINES; PROTEIN ISOFORMS; RANDOM ALLOCATION; RECEPTORS, RETINOIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SMOKING; VITAMINS;

ANIMALIA; NICOTIANA TABACUM;

EID: 33748143452     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327914nc5402_12     Document Type: Article

References (54)

1. IARC Working Group on the Evaluation of Cancer Preventive Agents: IARC Handbook on Cancer Prevention: Vol 2: Carotenoids. Lyon, France: IARC, 1998.
2. Vainio H and Rautalahti M: An international evaluation of the cancer preventive potential of carotenoids. Cancer Epidemiol Biomarkers Prev 7, 725-728, 1998.
3. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, et al.: Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 334, 1145-1149, 1996.
4. The Alpha-Tocopherol β-cCPSG: The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers: the Alpha-Tocopherol. Beta Carotene Cancer Prevention Study Group. N Engl J Med 330, 1029-1035, 1994.
5. Omenn GS, Goodman G, Thornquist M, Barnhart S, Balmes J, et al.: Chemoprevention of lung cancer: the beta-Carotene and Retinol Efficacy Trial (CARET) in high-risk smokers and asbestos-exposed workers. IARC Sci Publ 136, 67-85, 1996.
6. Woutersen RA, Wolterbeek AP, Appel MJ, van den Berg H, Goldbohm RA, et al.: Safety evaluation of synthetic beta-carotene. Crit Rev Toxicol 29, 515-542, 1999.
7. Wang XD, Liu C, Bronson RT, Smith DE, Krinsky NI, et al.: Retinoid signaling and activator protein-1 expression in ferrets given beta-carotene supplements and exposed to tobacco smoke. J Natl Cancer Inst 91, 60-66, 1999.
8. Elmadfa I, Rust P, Majehrzak D, Wagner KH, Genser D, et al.: Effects of beta-carotene supplementation on free radical mechanism in healthy adult subjects. Int J Vitam Nutr Res 74, 147-152, 2004.
9. Mayne ST, Walter M, Cartmel B, Goodwill WJ, Jr, and Blumberg J: Supplemental beta-carotene, smoking, and urinary F2-isoprostane excretion in patients with prior early stage head and neck cancer. Nutr Cancer 49, 1-6, 2004.
10. Paolini M, Cantelli-Forti G, Perocco P, Pedulli GF, Abdel-Rahman SZ, et al.: Co-carcinogenic effect of beta-carotene. Nature 398, 760-761, 1999.
11. Obermueller-Jevic UC, Espiritu I, Corbacho AM, Cross CE, and Witschi H: Lung tumor development in mice exposed to tobacco smoke and fed beta-carotene diets. Toxicol Sci 69, 23-29, 2002.
12. Stoner GD: Introduction to mouse lung tumorigenesis. Exp Lung Res 24, 375-383, 1998.
13. Stoner GD, Adam-Rodwell G, and Morse MA: Lung tumors in strain A mice: application for studies in cancer chemoprevention. J Cell Biochem Suppl 17F, 95-103, 1993.
14. Stoner GD: Lung tumors in strain A mice as a bioassay for carcinogenicity of environmental chemicals. Exp Lung Res 17, 405-423, 1991.
15. Shimkin MB and Stoner GD: Lung tumors in mice: application to carcinogenesis bioassay. Adv Cancer Res 21, 1-58, 1975.
16. Hecht SS: Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol 3, 461-469, 2002.
17. Hecht SS: Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol 11, 559-603, 1998.
18. Hecht SS: Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 91, 1194-1210, 1999.
19. Malkinson AM: Molecular comparison of human and mouse pulmonary adenocarcinomas. Exp Lung Res 24, 541-555, 1998.
20. Sargent LM, Senft JR, Lowry DT, Jefferson AM, Tyson FL, et al.: Specific chromosomal aberrations in mouse lung adcnocarcinoma cell lines detected by spectral karyotyping: a comparison with human lung adenocarcinoma. Cancer Res 62, 1152-1157, 2002.
21. Umegaki KAM, Hirola S, Uramoto H, and Esashi T: Simultaneous dietary supplementation of sodium cholate and beta-carotene markedly enhanced accumulation of beta-carotene in mice. J Nutr 125, 3081-3086, 1995.
22. Schweigert FJ, Trupsehueh A, and Hantschel C: Modulation of absorption of beta-carotene and tissue accumulation of beta-carotene and vitamin A by different surfactants in rats. Ann Nutr Metab 46, 200-204, 2002.
23. Goralczyk R, Bachmann H, Riss G, Lenz B, Wertz K, et al.: Beta-carotene effects in a tobacco smoke carcinogen-induced lung cancer model in vivo. Abstract for the 13th International Carotenoid Symposium. January 6-11, Honolulu, Hawaii, 2002.
24. Barua AB and Olson JA: Beta-carotene is converted primarily to retinoids in rats in vivo. Journal of Nutrition 130, 1996-2001, 2000.
25. Schweigert F: Metabolism of carotenoids in mammals. In: Biosynthesis and Metabolism: Vol. 3. Britton G, (ed). Basel, Switzerland: Birkhaeuser, 1998, pp 250-284.
26. Sun SY and Lotan R: Retinoids and their receptors in cancer development and chemoprevention. Crit Rev Oncol Hematol 41, 41-55, 2002.
27. Chambon P: A decade of molecular biology of retinoic acid receptors. Faseb J 10, 940-954, 1996.
28. Zutphen V: Principles of Laboratory Animal Science, Amsterdam: Elsevier, 1993.
29. Schierle J, Haerdi W, Faccin N, Buehler I, and Schuep W: Geometrical isomers of beta,beta-carotene. In: Carotenoids: Vol. IA: Isolation and Analysis, Britton GJL and Pfander H (ed). Basel, Switzerland: Birkhaeuser, 1995, pp 265-272.
30. Dungworth DL, Rittinghausen S, Schwartz L, et al.: Respiratory system and mesothelium. In: International Classification of Rodent Tumors: The Mouse, Mohr U (ed). Heidelberg: Springer-Verlag, 2001, pp 87-137.
31. Thurmann PA, Steffen J, Zwernemann C, Aebischer CP, Cohn W, et al.: Plasma concentration response to drinks containing beta-carotene as carrot juice or formulated as a water dispersible powder. Eur J Nutr 41, 228-235, 2002.
32. Aebischer J, Schierle J, and Schuep W: Simultaneous determination of retinol, tocopherols, carotene, and xanthophylls in plasma by means of reversed phase high performace liquid chromatography. In: Methods Enzymol: Vol. 299, Sies H (ed). New York: Academic Press, 1999, pp 348-362.
33. Vuillcumier J, Keller HE, Gysel D, and Hunziker F: Clinical chemical methods for the routine assessment of the vitamin status in human population: part I: the fat soluable vitamins A and E. and beta-carotene. Internat J Vit Nutr Res 53, 265-272, 1983.
34. Redlich CA, Grauer JN, Van Bennekum AM, Clever SL, Ponn RB, et al.: Characterization of carotenoid, vitamin A, and alpha-tocopheral levels in human lung tissue and pulmonary macrophages. Am J Respir Crit Care Med 154, 1436-1443, 1996.
35. Redlich CA, Blaner WS, Van Bennekum AM, Chung JS, Clever SL, et al.: Effect of supplementation with beta-carotene and vitamin A on lung nutrient levels. Cancer Epidemiol Biomarkers Prev 7, 211-214, 1998.
36. Khachik F, Carvalho L, Bernstein PS, Muir GJ, Zhao DY, et al.: Chemistry, distribution, and metabolism of tomato carotenoids and their impact on human health. Exp Biol Med (Maywood) 227, 845-851, 2002.
37. Schmitz HH, Poor CL, Gugger ET, and Erdman JW Jr: Analysis of carotenoids in human and animal tissues. Methods Enzymol 214, 102-116, 1993.
38. Schmitz HH, Poor CL, Wellman RB, and Erdman JW Jr: Concentrations of selected carotenoids and vitamin A in human liver, kidney and lung tissue. J Nutr 121, 1613-1621, 1991.
39. van Poppel G, van Aspert A, Heynen T, Vooys GP, and Ockhuizen T: The effect of beta-carotene on sputum cytology in smokers: a preliminary study. Eur J Cancer Prev 6, 294-299, 1997.
40. McLarty JW, Holiday DB, Girard WM, Yanagihara RH, Kummet TD, et al.: Beta-carotene, vitamin A, and lung cancer chemoprevention: results of an intermediate end point study. Am J Clin Nutr 62(6 Suppl), 1431S-1438S, 1995.
41. Conaway CC, Jiao D, Kelloff GJ, Steele VE, Rivenson A.: Chemopreventive potential of fumaric acid, N-acetylcysteine, N-(4-hydroxyphenyl) retinamide and beta-carotene for tobacco-nitrosamine-induced lung tumors in A/J mice. Cancer Lett 124, 85-93, 1998.
42. Balmer JE and Blomhoff R: Gene expression regulation by retinoic acid. L Lipid Res 43, 1773-1808, 2002.
43. Berard J, Laboune F, Mukuna M, Masse S, Kothary R, et al.: Lung tumors in mice expressing an antisense RARbeta2transgene. Faseb J 10, 1091-1097, 1996.
44. Toulouse A, Morin J, Dion PA, Houle B, and Bradley WE: RARbeta2 specificity in mediating RA inhibition of growth of lung cancer-derived cells. Lung Cancer 28, 127-137, 2000.
45. Virmani AK, Rathi A, Zochbaner-Muller S, Succhi N, Fukuyama Y, et al.: Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas. J Natl Cancer Inst 92, 1303-1307, 2000.
46. Belinsky SA, Devereux TR, Maronpot RR, Stoner GD, and Anderson MW: Relationship between the formation of promutagenic adducts and the activation of the K-ras protooncogene in lung tumors from A/J mice treated with nitrosamines. Cancer Res 49, 5305-5311, 1989.
47. Pulling LC, Vuillemenot BR, Hutt JA, Devereux TR, and Belinsky SA: Aberrant promoter hypermethylation of the death-associated protein kinase gene is early and frequent in murine lung tumors induced by cigarette smoke and tobacco carcinogens. Cancer Res 64, 3844-3848, 2004.
48. Lotan R: Roles of retinoids and their nuclear receptors in the development and prevention of upper aerodigestive tract cancers. Environ Health Perspect 105(Suppl 4), 985-988, 1997.
49. Khuri FR and Lotan R: Retinoids in lung cancer: friend, foe, or fellow traveler? J Clin Oncol 22, 3435-3437, 2004.
50. Khuri FR, Lotan R, Kemp BL, Lippman SM, Wu H, et al.: Retinoic acid receptor-beta as a prognostic indicator in stage 1 non-small-cell lung cancer. J Clin Oncol 18, 2798-2804, 2000.
51. Kim JS, Lee H, Kim H, Shim YM, Han J, et al.: Promoter methylation of retinoic acid receptor beta 2 and the development of second primary lung cancers in non-small-cell lung cancer. J Clin Oncol 22, 3443-3450, 2004.
52. Lin C, Wang XD, Bronson RT, Smith DE, Krinsky NI, et al.: Effects of physiological versus pharmacological beta-carotene supplementation on cell proliferation and histopathological changes in the lungs of cigarette smoke-exposed ferrets. Carcinogenesis 21, 2245-2253, 2000.
53. Prakash P, Liu C, Hu KQ, Krinsky NI, Russell RM, et al.: Beta-carotene and beta-apo-14′-carotenoic acid prevent the reduction of retinoic acid receptor beta in benzo[a]pyrene-treated normal human bronchial epithelial cells. J Nutr 134, 667-673, 2004.
54. Kuntz E, Hoeller U, Greatrix B, Lankin C, Seifert N, et al.: Retinoid signaling promoted by apocarotenals and beta-carotene in BEAS-2B human bronchioepithelial cells. Acta Angiologica (Poland) 10, 39, 2004.